Predictive Oncology - 15 Year Stock Price History | POAI
Historical daily share price chart and data for Predictive Oncology since 2010 adjusted for splits and dividends. The latest closing stock price for Predictive Oncology as of July 11, 2025 is 0.79.
- The all-time high Predictive Oncology stock closing price was 262500.00 on July 11, 2011.
- The Predictive Oncology 52-week high stock price is 3.06, which is 287.3% above the current share price.
- The Predictive Oncology 52-week low stock price is 0.55, which is 30.4% below the current share price.
- The average Predictive Oncology stock price for the last 52 weeks is 1.01.
| Predictive Oncology Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 1.1627 | 0.9200 | 1.9500 | 0.7900 | 0.7900 | -3.66% |
| 2024 | 1.5439 | 3.5250 | 3.6701 | 0.5501 | 0.8200 | -75.08% |
| 2023 | 5.0178 | 6.3200 | 12.1400 | 2.5900 | 3.2900 | -46.42% |
| 2022 | 10.9669 | 19.7600 | 21.6000 | 4.8600 | 6.1400 | -67.75% |
| 2021 | 23.7090 | 14.4000 | 44.0000 | 14.4000 | 19.0400 | 30.05% |
| 2020 | 29.1921 | 50.5800 | 69.6000 | 13.2000 | 14.6400 | -71.95% |
| 2019 | 125.0307 | 130.0000 | 219.0000 | 52.2000 | 52.2000 | -57.84% |
| 2018 | 204.4247 | 194.2000 | 278.0000 | 122.6000 | 123.8000 | -38.71% |
| 2017 | 352.6717 | 536.0000 | 616.0000 | 202.0000 | 202.0000 | -63.93% |
| 2016 | 2945.2897 | 15100.0000 | 18965.0000 | 314.0000 | 560.0000 | -96.19% |
| 2015 | 19930.2976 | 30000.0000 | 35550.0000 | 12000.0000 | 14700.0000 | -54.77% |
| 2014 | 58327.1825 | 103125.0000 | 103125.0000 | 20000.0000 | 32500.0000 | -67.90% |
| 2013 | 74465.7738 | 45000.0000 | 157500.0000 | 19125.0000 | 101250.0000 | 125.00% |
| 2012 | 38092.5000 | 105000.0000 | 123750.0000 | 11250.0000 | 45000.0000 | -57.14% |
| 2011 | 77248.5119 | 41250.0000 | 262500.0000 | 18750.0000 | 105000.0000 | 154.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.084B | 57.36 |
| Doximity (DOCS) | United States | $11.307B | 52.35 |
| Hims & Hers Health (HIMS) | United States | $10.719B | 111.37 |
| Tempus AI (TEM) | United States | $9.847B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.340B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.717B | 0.00 |
| Privia Health (PRVA) | United States | $2.496B | 170.58 |
| Enovis (ENOV) | United States | $1.944B | 10.84 |
| Phreesia (PHR) | United States | $1.590B | 0.00 |
| 10x Genomics (TXG) | United States | $1.576B | 0.00 |
| Schrodinger (SDGR) | United States | $1.542B | 0.00 |
| Azenta (AZTA) | United States | $1.532B | 71.21 |
| Clover Health Investments (CLOV) | United States | $1.486B | 0.00 |
| Omnicell (OMCL) | United States | $1.344B | 23.71 |
| Evolent Health (EVH) | United States | $1.313B | 111.80 |
| Claritev (CTEV) | United States | $0.761B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
| Veradigm (MDRX) | United States | $0.547B | 0.00 |
| Standard BioTools (LAB) | United States | $0.501B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.442B | 132.00 |
| Outset Medical (OM) | United States | $0.344B | 0.00 |
| TruBridge (TBRG) | United States | $0.331B | 735.33 |
| Health Catalyst (HCAT) | United States | $0.271B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.258B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| CapsoVision (CV) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.150B | 0.00 |
| American Well (AMWL) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| Pulmonx (LUNG) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.84 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.068B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |